PATENT CLAIM ANALYSIS

Application Number: 16170733
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "359000"]

Abstract:
The present invention provides pharmacological compounds including an effector moiety conjugated to a binding moiety that directs the effector moiety to a biological target of interest. Likewise, the present invention provides compositions, kits, and methods (e.g., therapeutic, diagnostic, and imaging) including the compounds. The compounds can be described as a protein interacting binding moiety-drug conjugate (SDC-TRAP) compounds, which include a protein interacting binding moiety and an effector moiety. For example, in certain embodiments directed to treating cancer, the SDC-TRAP can include an Hsp90 inhibitor conjugated to a cytotoxic agent as the effector moiety.

Claim (Index 3):
The method of  claim 2 , wherein the cancer is lung cancer, colon cancer, breast cancer, skin cancer, or bladder cancer.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.92982
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14510518', '15251255', '15266411', '15138785', '15222145']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8395953579117637
- 35 USC 102 Novelty (BERT): 0.5528180529174544
- Combined Prediction Score: 0.8109176274123328
- Mean Citation Score: 439.612942
- Max Citation Score: 494.67075
- Similarity Product: 269.765605122596

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test